Tracy Hall
Sports Medicine · Greenville, ILNPI 1659366102
Payments from drug & device makers
Across 423 payments — averaging $17.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$1K
- Lilly USA, LLC$717
- Novo Nordisk$621
- GSK$326
- Boehringer Ingelheim$283
- plus $2K from 31 others
What the payments were for
- Consulting fees$77010%
- Food & beverage$6,67690%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 101 | $2,177 |
| AstraZeneca | 76 | $1,328 |
| Lilly USA, LLC | 39 | $717 |
| Novo Nordisk | 47 | $621 |
| GSK | 20 | $326 |
| Boehringer Ingelheim | 12 | $283 |
| Pfizer | 24 | $230 |
| Sanofi-aventis U.S. LLC | 12 | $202 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $176 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $163 |
| Merck | 9 | $136 |
| Kowa Pharmaceuticals America, Inc. | 8 | $116 |
| Exact Sciences | 6 | $97 |
| Johnson & Johnson | 5 | $94 |
| Amgen | 4 | $68 |
| Astellas Pharma US Inc | 4 | $63 |
| Amarin Pharma, Inc. | 4 | $61 |
| Phathom Pharmaceuticals, Inc. | 3 | $54 |
| Radius Health, Inc. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Lundbeck LLC | 2 | $38 |
| Novartis | 2 | $36 |
| Medicure Pharma Inc. | 2 | $32 |
| Abbott | 2 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Dexcom, Inc. | 2 | $28 |
| Esperion Therapeutics, Inc. | 1 | $25 |
| Nestle Healthcare Nutrition Inc. | 2 | $23 |
| Eisai Inc. | 1 | $22 |
| Amneal Pharmaceuticals LLC | 1 | $21 |
| Bayer | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Calliditas Therapeutics US Inc. | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
| Electromed, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,446 in reported general payments places this provider in the 70th percentile of 233 sports medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 111 | $115,465 |
| OzempicSemaglutide | 67 | $110,473 |
| MounjaroTirzepatide | 41 | $78,834 |
| JardianceEmpagliflozin | 44 | $53,557 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $22,444 |
| Hysingla ErHydrocodone Bitartrate | 12 | $22,328 |
| XareltoRivaroxaban | 31 | $21,776 |
| JanuviaSitagliptin Phosphate | 22 | $21,524 |
| Breo ElliptaFluticasone/Vilanterol | 34 | $16,825 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $13,174 |
| MyrbetriqMirabegron | 12 | $7,480 |
| LinzessLinaclotide | 12 | $6,945 |
| Colesevelam Hcl | 16 | $4,607 |
| Arnuity ElliptaFluticasone Furoate | 17 | $4,453 |
| DuleraMometasone/Formoterol | 12 | $4,244 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $230 | $115,465111 claims |
| Novo NordiskOzempic | $621 | $110,47367 claims |
| Lilly USA, LLCMounjaro | $717 | $78,83441 claims |
| Boehringer IngelheimJardiance | $283 | $53,55744 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $326 | $43,72175 claims |
| MerckJanuvia, Dulera | $136 | $25,76834 claims |
| Johnson & JohnsonXarelto | $94 | $21,77631 claims |
| AstraZenecaBreztri Aerosphere | $1,328 | $13,17412 claims |
| AbbVieLinzess, Synthroid | $2,177 | $10,76359 claims |
| Astellas Pharma US IncMyrbetriq | $63 | $7,48012 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $21 | $3,565449 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 233 sports medicine providers in Illinois.
Other sports medicine in Greenville
- Benjamin DombDes Plaines$18.1M
- Gregory NicholsonChicago$6.7M
- Grant GarriguesChicago$3.1M
- Brian ColeChicago$3.1M
- Brian ForsytheChicago$2M
- Nikhil VermaChicago$1M
- Shane NhoChicago$668K
- Adam YankeChicago$388K
- Jason KohSkokie$227K
- Jourdan CancienneJoliet$224K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.